| Financial Year |
March 31 2023 |
| Monetary Funds |
3,021,927.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,108,592.34 |
| Advances to Suppliers |
-- |
| Other Receivables |
695,042.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,384,629.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,550,174.01 |
| Total Current Assets |
19,760,365.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,179,037,171.41 |
| Investment Properties |
-- |
| Fixed Assetes |
926,791.29 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,900.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
48,803,586.19 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,371,045,635.66 |
| Total Assets |
5,390,806,001.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
77,313,836.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,339,098.65 |
| Taxes Payable |
446,178.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
51,585,459.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,719,005.54 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
163,354,352.91 |
| Long-term Loans |
197,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
395,879,591.06 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
755,441,824.98 |
| Total Liabilities |
918,796,177.89 |
| Paid-In Capital(Or Share Stock) |
1,430,234,425.00 |
| Capital Surplus |
52,446,617.01 |
| Surplus Reserve |
368,348,766.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,042,061,793.48 |
| Minority Stockholder's Interest |
466,766,523.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,005,243,300.41 |
| Owner's Equity（Stockholder's Equity） |
4,472,009,823.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,390,806,001.40 |
